NVCR
NovoCure Ltd
Key Financials
Net Income
$-136227000
↑ 19.2%
Gross Profit
$488.5M
↑ 4.4%
Revenue
$655.4M
↑ 8.3%
EPS (Diluted)
$-1.22
↑ 21.8%
Operating Income
$-153800000
↑ 9.8%
Shareholders' Equity
$340.5M
↓ 5.5%
Total Liabilities
$463.9M
↓ 47.3%
Total Assets
$804.3M
↓ 35.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/9/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 8-K | 3/26/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NVCR |
| Company Name | NovoCure Ltd |
| CIK | 1645113 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 44 (0)15 3475 6700 |